IP Verse

Wuesthoff & Wuesthoff competitive analysis

Latest oppositions filed by Wuesthoff & Wuesthoff

Explore patent oppositions filed by Wuesthoff & Wuesthoff against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026
Patent NumberTitleApplicantOpposition Date
EP4188389
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAJun 16, 2026
EP4406594
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofF HOFFMANN LA ROCHEJun 9, 2026
EP4121007
High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use ThereofEISAI R&D MANAGEMENTApr 1, 2026
EP3858859
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBMar 12, 2026
EP4076569
Cassette Design And Systems And Methods ThereofJOHNSON & JOHNSON SURGICAL VISIONFeb 5, 2026
EP3539540
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025
EP3171860
Solid Oral Formulation Of FenretinideLAURENT PHARMACEUTICALSSep 9, 2025
EP3509637
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XCHUGAI SEIYAKU KABUSHIKI KAISHAAug 25, 2025
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 6, 2025
EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025

Latest PTAB cases involving Wuesthoff & Wuesthoff

Discover the latest PTAB cases involving Wuesthoff & Wuesthoff, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Wuesthoff & Wuesthoff with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB35 - - -
CELGENE - 72 - 11
NOVARTIS6472 - 21
REGENERON PHARMACEUTICALS38120932